| Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background (NCT02053727) | University of California, Los Angeles | 2014-07-01 |
| A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs. (NCT02011334) | Hoffmann-La Roche | 2014-07-01 |
| Persona Total Knee Arthroplasty Outcomes Study (NCT02255383) | Zimmer Biomet | 2014-07-01 |
| ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate (NCT01984268) | Dartmouth-Hitchcock Medical Center | 2014-06-23 |
| A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate (NCT02147587) | Pfizer | 2014-06-01 |
| Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate (NCT02202395) | Shanghai Pharmaceuticals Holding Co., Ltd | 2014-06-01 |
| Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis (NCT02277574) | MedImmune LLC | 2014-06-01 |
| CARNet : Self-Monitoring and Co-driving in Rheumatology With Internet : Rheumatoid Arthritis Cohort (Usual Care Study) (NCT02200068) | Association Accompagnement pour un Internet en Médecine et Santé au Service des Usagers | 2014-06-01 |
| A Study of Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs) (NCT02046616) | Hoffmann-La Roche | 2014-05-28 |
| Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice (NCT02251860) | Hoffmann-La Roche | 2014-05-20 |
| Sleep Quality in Patients With Rheumatoid Arthritis (NCT04278170) | Istanbul Physical Medicine Rehabilitation Training and Research Hospital | 2014-05-15 |
| The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept (NCT03604406) | Kevin Winthrop | 2014-05-08 |
| Evaluation of the Condition of Rheumatoid Arthritis After Treatment (NCT02157012) | Shinshu University | 2014-05-01 |
| Tight Control of Disease Activity Among Patients With RA Based on a Systematic Telemedicine Treatment Strategy (NCT02155894) | University of Aarhus | 2014-05-01 |
| Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA) (NCT02115750) | Coherus Oncology, Inc. | 2014-05-01 |
| A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy (NCT02167139) | Samsung Bioepis Co., Ltd. | 2014-05-01 |
| INCB047986 in Rheumatoid Arthritis (NCT02151474) | Incyte Corporation | 2014-05-01 |
| Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Trial (NCT02140866) | Parker Research Institute | 2014-05-01 |
| Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (NCT04582084) | AryoGen Pharmed Co. | 2014-04-04 |
| Rheumatology Informatics System for Effectiveness (NCT02230943) | American College of Rheumatology | 2014-04-01 |
| Etanercept in Rheumatoid Arthritis and Vascular Inflammation (NCT02109289) | Innovaderm Research Inc. | 2014-04-01 |
| Effects of Fasting on Self Efficacy (NCT02113111) | Universität Duisburg-Essen | 2014-04-01 |
| ALX-0061 Phase I Bioavailability Study in Healthy Volunteers (NCT02101073) | Ablynx, a Sanofi company | 2014-03-31 |
| A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone (NCT02066389) | AbbVie | 2014-03-26 |
| A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent (NCT02046603) | Hoffmann-La Roche | 2014-03-04 |
| Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA) (NCT02097524) | Regeneron Pharmaceuticals | 2014-03-01 |
| Acute Effect of Resistance Training in Inflammatory Markers in Women With Rheumatoid Arthritis (NCT02401958) | Federal University of São Paulo | 2014-03-01 |
| Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA) (NCT02094326) | Fundación Andaluza de Reumatología | 2014-03-01 |
| The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis (NCT02029599) | Maoxiang Group Jilin Pharmaceutical Co., Ltd. | 2014-03-01 |
| Zimmer Trabecular Metal Total Ankle PMCF (NCT02038140) | Zimmer Biomet | 2014-03-01 |
| Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants (NCT02065700) | Lakefront Biotherapeutics NV | 2014-02-25 |
| Adipokines as Predictors of Foot Function, Pain, and Disability in Patients With Rheumatoid Arthritis (NCT04036669) | King Saud University | 2014-02-20 |
| Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis (NCT02434757) | Ronald J. Rapoport, MD | 2014-02-01 |
| The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis (NCT02078375) | Johns Hopkins University | 2014-02-01 |
| Discovering the Antecedents of Rheumatoid Arthritis Flare (NCT02051114) | Rockefeller University | 2014-02-01 |
| Study Evaluating the Efficacy of Thick Shell Mussel Lipid Extract in Chinese Subjects With Rheumatoid Arthritis (NCT02173587) | Zhejiang University | 2014-02-01 |
| Robotic Arm Assisted Total Knee Arthroplasty (NCT02058069) | MAKO Surgical Corp. | 2014-02-01 |
| Pilot Study of Ultrasound in Rheumatoid Arthritis (NCT02064400) | Newcastle-upon-Tyne Hospitals NHS Trust | 2014-02-01 |
| Full Mouth Disinfection and Antibiotics for Periodontitis in High or Moderate Disease Activity Rheumatoid Arthritis (NCT02096120) | Insel Gruppe AG, University Hospital Bern | 2014-02-01 |
| Post-marketing Study Assessing the Long-Term Safety of Abatacept (NCT02169544) | Bristol-Myers Squibb | 2014-01-31 |
| A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis (NCT01987479) | Hoffmann-La Roche | 2014-01-30 |
| An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis (NCT02049138) | AbbVie | 2014-01-24 |
| Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases (NCT01988506) | Assistance Publique - Hôpitaux de Paris | 2014-01-06 |
| Sarilumab Effect on the Pharmacokinetics of Simvastatin (NCT02017639) | Sanofi | 2014-01-01 |
| A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy (NCT02001987) | Hoffmann-La Roche | 2014-01-01 |
| GotNet Study, The Gothenburg Nurse-led Tight Control Study (NCT02019901) | Vastra Gotaland Region | 2014-01-01 |
| A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis. (NCT01988012) | Hoffmann-La Roche | 2014-01-01 |
| Injections of FloGraft Therapy, Autologous Stem Cells, or Platelet Rich Plasma for the Treatment of Degenerative Joint Pain (NCT01978639) | Arizona Pain Specialists | 2014-01-01 |
| Validation of a Tolerability Questionnaire in Rheumatoid Arthritis (NCT02401620) | Corporacion Parc Tauli | 2014-01-01 |
| Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab (NCT01981473) | Pfizer | 2014-01-01 |
| A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta (NCT02019602) | UCB BIOSCIENCES, Inc. | 2014-01-01 |
| Depression and Anxiety in Rheumatoid Arthritis (NCT02122406) | University of Pavia | 2014-01-01 |
| TOSCARA Study: A Study of Subcutaneous Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis Naïve to RoActemra/Actemra Treatment (NCT02031471) | Hoffmann-La Roche | 2014-01-01 |
| An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients. (NCT02590562) | Hoffmann-La Roche | 2013-12-31 |
| An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA (NCT02557295) | Celltrion | 2013-12-17 |
| (C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis (NCT02047604) | Bausch Health Americas, Inc. | 2013-12-01 |
| Targeted Ultrasound in Rheumatoid Arthritis (NCT02056184) | University of Leeds | 2013-12-01 |
| Reconstitution of CD4+CD25highCD127low/-Tcell (NCT03736044) | University Hospital of Ferrara | 2013-11-25 |
| A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis (NCT01941095) | Hoffmann-La Roche | 2013-11-20 |
| Zimmer POLAR Persona - TKA (EMEA Study) (NCT02337244) | Zimmer, GmbH | 2013-11-18 |
| A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX (NCT01855789) | Hoffmann-La Roche | 2013-11-07 |
| NFKB1 and IKK Epsilon in Rheumatoid Arthritis (NCT02689115) | Asociación Científica Latina A.C. | 2013-11-01 |
| Fatigue in People With Rheumatoid Arthritis- Randomized Controlled Trial (NCT02120963) | Göteborg University | 2013-11-01 |
| Trial of a Physical Activity Intervention for RA Fatigue (NCT01874977) | University of California, San Francisco | 2013-11-01 |
| Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine (NCT01980836) | Tel-Aviv Sourasky Medical Center | 2013-11-01 |
| Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED) (NCT02005757) | Chong Kun Dang Pharmaceutical | 2013-11-01 |
| The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis (NCT02254655) | Chengdu PLA General Hospital | 2013-11-01 |
| RICE: Remission by Intra-articular Injection Plus CErtolizumab (NCT02293590) | Rüdiger B. Müller | 2013-11-01 |
| Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis (NCT01990157) | Theramab LLC | 2013-11-01 |
| An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT01951170) | Hoffmann-La Roche | 2013-11-01 |
| Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study (NCT02027298) | The Cleveland Clinic | 2013-11-01 |
| Comprehensive Nano - Post Market Clinical Follow-Up Study (NCT03423953) | Zimmer Biomet | 2013-10-30 |
| Zimmer POLAR - Total Knee Arthroplasty (TKA) (NCT01859130) | Zimmer Biomet | 2013-10-21 |
| Perioperative Flare in RA: Characterization of Clinical and Biological Features (NCT02111057) | Hospital for Special Surgery, New York | 2013-10-16 |
| Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2) (NCT01894516) | Lakefront Biotherapeutics NV | 2013-10-08 |
| The Effects of Cardiac Rehabilitation on Cardiovascular Disease Risk in Rheumatoid Arthritis Patients (NCT01534871) | Nova Scotia Health Authority | 2013-10-02 |
| Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects (NCT01962337) | Five Prime Therapeutics, Inc. | 2013-10-01 |
| A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy (NCT01960855) | AbbVie | 2013-10-01 |
| AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment (NCT01973569) | Daiichi Sankyo | 2013-10-01 |
| Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis (NCT01999192) | Biotest | 2013-10-01 |
| Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies. (NCT01966718) | Arthritis Treatment Center, Maryland | 2013-10-01 |
| A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis (NCT01952509) | Hoffmann-La Roche | 2013-10-01 |
| Novel Imaging Markers for Rheumatoid Arthritis (NCT01773681) | University of California, San Francisco | 2013-10-01 |
| Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis (NCT01975610) | Celgene | 2013-10-01 |
| C-GLOVES: the Effectiveness of Compression Gloves in Arthritis (NCT01874067) | University of Salford | 2013-10-01 |
| Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis (NCT01985464) | Translational Biosciences | 2013-10-01 |
| VACcination In Methotrexate Treated Rheumatoid Arthritis Patients (NCT01942174) | University Hospital, Montpellier | 2013-09-27 |
| Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients (NCT01907230) | Taipei Veterans General Hospital, Taiwan | 2013-09-10 |
| A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants (NCT01941940) | Hoffmann-La Roche | 2013-09-05 |
| The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients (NCT01948388) | Gaylis, Norman B., M.D. | 2013-09-01 |
| The Health Log: A Randomized Clinical Trial (NCT01913080) | Brigham and Women's Hospital | 2013-09-01 |
| Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis (NCT02275299) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2013-09-01 |
| A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid Arthritis (NCT01995201) | Hoffmann-La Roche | 2013-09-01 |
| A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered to Subjects With Moderate to Severe Rheumatoid Arthritis (NCT01955603) | Novo Nordisk A/S | 2013-09-01 |
| Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL (NCT02600455) | Bristol-Myers Squibb | 2013-09-01 |
| Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate (NCT01783015) | Pfizer | 2013-09-01 |
| Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg (NCT02600468) | Bristol-Myers Squibb | 2013-09-01 |
| Arthritis Health Journal Proof of Concept Study (NCT01941433) | University of British Columbia | 2013-09-01 |
| A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy (NCT01936181) | Samsung Bioepis Co., Ltd. | 2013-08-01 |
| A Safety and Efficacy of Homeopathic Medicine Rhus Toxicodendron 30 in the Treatment of Rheumatoid Arthritis (NCT01905735) | Healthcare Homoeo Charitable Society | 2013-08-01 |